Breast cancer susceptibility genes

被引:2
作者
Díez, O
Gutiérrez-Enríquez, S
Cajal, TRY
机构
[1] Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona 08025, Spain
[2] Hosp Santa Creu & Sant Pau, Med Oncol Serv, Barcelona 08025, Spain
来源
MEDICINA CLINICA | 2006年 / 126卷 / 08期
关键词
hereditary breast cancer; BRCA1; BRCA2; ATM; CHEK2;
D O I
10.1157/13085493
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Five percent of all cases of breast cancer (BC) show a hereditary component related to gene mutations with an autosomic dominant transmission. To date, few genes are known to be responsible of hereditary BC. The germline mutations of BRCA1 or BRCA2 genes account for less than 50% of families with breast/ovarian cancer predisposition. The large percentage of families with multiple cases of female BC and no BRCA1 and BRCA2 mutations detected could be attributed to the existence of other high or low susceptibility genes acting together with lifestyle risk factors. The predisposition to BC in carriers of ATM mutations has been documented previously. Due to the frequency of ATM heterozygotes in the general population, the mutations in this gene could be associated with up to 5% of BC cases. The mutation 1100delC of the CHEK2 gene seems to be a low penetrance allele of BC susceptibility. The objective of the present manuscript is to review some of the susceptibility genes identified to date.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 64 条
[1]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[2]  
Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173
[3]   Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography [J].
Atencio, DP ;
Iannuzzi, CM ;
Green, S ;
Stock, RG ;
Bernstein, JL ;
Rosenstein, BS .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2001, 38 (2-3) :200-208
[4]   The 185delAG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim [J].
Bar-Sade, RB ;
Kruglikova, A ;
Modan, B ;
Gak, E ;
Hirsh-Yechezkel, G ;
Theodor, L ;
Novikov, I ;
Gershoni-Baruch, R ;
Risel, S ;
Papa, MZ ;
Ben-Baruch, G ;
Friedman, E .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :801-805
[5]   Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease [J].
Beral, V ;
Bull, D ;
Doll, R ;
Peto, R ;
Reeves, G .
LANCET, 2001, 358 (9291) :1389-1399
[6]   BRCA1 and BRCA2 mutations in patients with familial breast cancer [J].
Bolufer, P ;
Munárriz, B ;
Santaballa, A ;
Velasco, E ;
Lerma, E ;
Barragán, E .
MEDICINA CLINICA, 2005, 124 (01) :10-12
[7]  
Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310
[8]  
Chen JD, 1998, CANCER RES, V58, P1376
[9]  
Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205
[10]   Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families:: Implications for genetic testing [J].
de la Hoya, M ;
Osorio, A ;
Godino, J ;
Sulleiro, S ;
Tosar, A ;
Perez-Segura, P ;
Fernandez, C ;
Rodríguez, R ;
Díaz-Rubio, E ;
Benítez, J ;
Devilee, P ;
Caldés, T .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (04) :466-471